Emmanuel Ligner has deep roots in biopharma, leadership, and engineering. He’s driven to bringing transformative health to patients through researchers, hospitals, and the pharmaceutical partners of Cytiva. He’s been the President and CEO of Cytiva since July 2017, when it was known as GE Healthcare Life Sciences. He led the company to more than 7% revenue and 13% operating profit growth. In 2021, he was appointed Group Executive of the Danaher Biotechnology Group, consisting of Cytiva and Pall Life Sciences, which is within the Danaher Life Sciences Platform.
.svg)
